Avacta Group (AVCTF) Stock Price, News & Analysis

Company Overview

Avacta Group plc is a United Kingdom-based life sciences company focused on developing targeted cancer treatments. Its principal technology platform, pre|CISION, is designed to activate medicines selectively within the tumor microenvironment, with the goal of improving treatment effectiveness while reducing exposure to healthy tissue.

The company’s lead clinical program is AVA6000, a tumor-activated form of doxorubicin being investigated for the treatment of solid tumors, including soft-tissue sarcoma. Avacta is also developing additional pre|CISION-based therapeutic candidates and has used its Affimer biologics platform to support the discovery and development of engineered binding proteins for therapeutic applications.

Avacta was established in 2003 and has historically operated across therapeutics and diagnostics, including collaborations and services for pharmaceutical, biotechnology and diagnostic companies. The group is headquartered in the United Kingdom and works with international commercial and research partners. Its shares trade on the London Stock Exchange, with the company also represented in the U.S. over-the-counter market under the symbol AVCTF.

Key Stats

• Today's Range: $0.85 to $0.85
• 50-Day Range: $0.85 to $1.05
• 52-Week Range: $0.74 to $1.23
• Volume: N/A
• Average Volume: 22,464 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:AVCTF
• CIK: N/A
• Web: www.avacta.com
• Phone: 44.1904.21.7070
• Fax: N/A
• Employees: 120
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A